Ignite Creation Date:
2025-12-25 @ 2:40 AM
Ignite Modification Date:
2025-12-28 @ 7:41 PM
Study NCT ID:
NCT01239134
Status:
COMPLETED
Last Update Posted:
2025-08-03
First Post:
2010-11-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trial of TRX518 (Anti-GITR mAb) in Stage III or IV Malignant Melanoma or Other Solid Tumors
Sponsor:
Leap Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-10
Start Date Type:
ACTUAL
Primary Completion Date:
2018-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-09
Completion Date Type:
ACTUAL
First Submit Date:
2010-11-09
First Submit QC Date:
None
Study First Post Date:
2010-11-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-30
Last Update Post Date:
2025-08-03
Last Update Post Date Type:
ACTUAL